Riskpilot← Back to searchSign inGet full accessLARS WEFRING AS
ASActiveOrg 915669697Jessnesvegen 388, 2320 FurnesGeneral medical practice activities · NACE 8621Est. 20151 employees
Revenue 2025
NOK 174K
-16% vs 2024
EBITDA margin
25.4%
+151% vs 2024
Equity ratio
89.0%
Financial strength
Net profit 2025
NOK 105K
-88% vs 2024
| Revenue | NOK 174K | -16% |
| EBITDA | NOK 44K | +151% |
| Net profit | NOK 105K | -88% |
| Total assets | NOK 2,7M | -8% |
| Equity | NOK 2,4M | -7% |
| Employees | 1 | — |
Legal name
LARS WEFRING AS
Org number
915669697
Legal form
Aksjeselskap
NACE code
8621 · General medical practice activities
Founded
15. juli 2015
Share capital
NOK 40 000
Employees
1 (FTE)
VAT registered
No
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Styrets leder alene.
Company purpose
Medisinsk behandling, kurs-, foredrags- og undervisningsvirksomhet, utarbeidelse av spesialisterklæringer og sakkyndige oppdrag, konsulentvirksomhet og forvaltning av selskapets kapital og ressurser i form av investeringsvirksomhet, deltakelse i andre selskaper, finansforvaltning, kjøp, drift, oppføring og rehabilitering av fast eiendom.
Address
Jessnesvegen 388, 2320 Furnes
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 48 | 125 | 120 | 95 | 59 | 17 | 24 | 59 | 390 | 208 | 174 |
| Staff expenses | −0 | −0 | −0 | −0 | −0 | −0 | −14 | −19 | −17 | −130 | −10 |
| EBITDA | 43 | 81 | 104 | 80 | 46 | −35 | −96 | −58 | 228 | −87 | 44 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 |
| EBIT | 43 | 81 | 104 | 80 | 46 | −35 | −96 | −58 | 228 | −87 | 44 |
| Net financials | 0 | 460 | 451 | 484 | 431 | 371 | 1 135 | 900 | 800 | 944 | 67 |
| Profit before tax | 43 | 542 | 554 | 563 | 477 | 336 | 1 039 | 842 | 1 028 | 857 | 111 |
| Tax | 10 | 20 | 25 | 21 | 10 | −0 | −0 | −0 | 2 | −0 | 6 |
| Net profit | 33 | 521 | 529 | 542 | 467 | 336 | 1 039 | 842 | 1 026 | 857 | 105 |
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 78 | 617 | 1 147 | 1 681 | 2 140 | 2 470 | 3 516 | 2 251 | 2 474 | 2 961 | 2 732 |
| Equity | 67 | 589 | 1 118 | 1 660 | 2 127 | 2 463 | 3 502 | 2 244 | 2 470 | 2 627 | 2 432 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 10 | 29 | 29 | 21 | 13 | 8 | 14 | 7 | 4 | 334 | 300 |
| Total debt | 10 | 29 | 29 | 21 | 13 | 8 | 14 | 7 | 4 | 334 | 300 |
EBITDA margin
25.4%
This company
15.8%
Market median
+61% vs market
20152025
Equity ratio
89.0%
This company
38.2%
Market median
+133% vs market
20152025
Return on equity
4.3%
This company
18.4%
Market median
-77% vs market
20152025
Net profit margin
60.6%
This company
8.1%
Market median
+648% vs market
20152025
Asset turnover
0.06×
This company
1.12×
Market median
-95% vs market
20152025
Debt / equity
0.12×
This company
0.62×
Market median
+81% vs market
20152025
- Annual report 2025Filed via Brønnøysundsregistrene · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Brønnøysundsregistrene · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Brønnøysundsregistrene · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Brønnøysundsregistrene · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via Brønnøysundsregistrene · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via Brønnøysundsregistrene · Period 2015-01-01 – 2015-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
LW Chief Executive Officer | Chief Executive Officer | 2015 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2015 | — | — |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
LARS WEFRING AS 
Nova-Cure AsBoard members of LARS WEFRING AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Lars Wefring | Chief Executive Officer | 0 companies |
| Inger Eline Wetten Tjønneland | Board of Directors | 0 companies |